{"id":3662,"date":"2025-03-31T18:11:46","date_gmt":"2025-03-31T18:11:46","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/kdc\/acipimox-txt\/"},"modified":"2025-03-31T18:11:46","modified_gmt":"2025-03-31T18:11:46","slug":"acipimox-txt","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/kdc\/acipimox-txt\/","title":{"rendered":"Acipimox.txt"},"content":{"rendered":"<h1>Acipimox<\/h1>\n<p><H3>  CLINICAL USE <\/H3><br \/>\nHyperlipidaemia<br \/>\n<H3> DOSE IN NORMAL RENAL FUNCTION  <\/H3><br \/>\n250 mg 2 or 3 times daily<br \/>\n<H3>  PHARMACOKINETICS    <\/H3><br \/>\n<LI> Molecular weight &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n154.1\n<\/li>\n<li>  %Protein binding  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp  &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n0\n<\/li>\n<li>  %Excreted unchanged in urine &amp;nbsp &amp;nbsp :<br \/>\n86\u201390\n<\/li>\n<p><LI> Volume of distribution (L\/kg) &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n0.3\u20130.4\n<\/li>\n<p><LI>half-life \u2013 normal\/ESRD (hrs)&amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\n2\/Increased<br \/>\n<H3>  DOSE IN RENAL IMPAIRMENT <\/H3><br \/>\n<H4>GFR (mL\/MIN)<\/H4><br \/>\n40\u201380 250 mg daily<br \/>\n20\u201340 250 mg alternate days.<br \/>\n&lt;20<br \/>\nSee \u2018Other Information\u2019<br \/>\n<H3> DOSE IN PATIENTS UNDERGOING RENAL REPLACEMENT THERAPIES  <\/H3><br \/>\n<LI> CAPD  &amp;nbsp &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp:<br \/>\nLikely dialysability. Dose as in<br \/>\nGFR&lt;20 mL\/min<\/p>\n<li> HD &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp  &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp :<br \/>\nDialysed. Dose as in<br \/>\nGFR&lt;20 mL\/min<br \/>\n<LI>HDF\/high flux  &amp;nbsp :<br \/>\nDialysed. Dose as in<br \/>\nGFR&lt;20 mL\/min<br \/>\n<LI>CAV\/VVHD  &amp;nbsp &amp;nbsp &amp;nbsp:<br \/>\nDialysed. Dose as in<br \/>\nGFR=20\u201340 mL\/min<br \/>\n<H3> IMPORTANT DRUG INTERACTIONS  <\/H3><br \/>\nPotentially hazardous interactions with other drugs<\/p>\n<li>None known\n<p><H3> ADMINISTRATION  <\/H3><br \/>\n<H4> Reconstition<\/H4><br \/>\n\u2013<br \/>\n<H4>  Route  <\/H4><br \/>\nOral<\/p>\n<p><H4>  Rate of Administration  <\/H4><br \/>\n\u2013<br \/>\n<H4>Comments<\/H4><br \/>\nTake with or after meals<\/p>\n<p><H4>  OTHER INFORMATION  <\/H4><\/p>\n<li>Females are twice as likely as males to\n<p>suffer from side effects, e.g. flushing,<br \/>\npruritus and skin rashes<\/p>\n<li>Doses up to 1200 mg have been given\n<p>safely for long periods<br \/>\nAfter a 5 hour dialysis 70% of the drug had <\/p>\n<p>been removed<\/p>\n<li>Dollery advises the doses given in the\n<p>table, down to 20 mL\/minute, but nothing<br \/>\nafter that.<br \/>\nMicromedex gives the following <\/p>\n<p>recommendations:<br \/>\nGFR: 30\u201360 mL\/min 150 mg twice daily<br \/>\nGFR: 10\u201330 mL\/min 150 mg once daily<br \/>\nGFR: <LI> &lt;10 &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp &amp;nbsp : mL\/min 150 mg alternate days<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Acipimox CLINICAL USE Hyperlipidaemia DOSE IN NORMAL RENAL FUNCTION 250<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[7],"class_list":["post-3662","post","type-post","status-publish","format-standard","hentry","category-blog","tag-post-by-auto-php"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3662","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/comments?post=3662"}],"version-history":[{"count":0,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/posts\/3662\/revisions"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/media?parent=3662"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/categories?post=3662"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/kdc\/wp-json\/wp\/v2\/tags?post=3662"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}